People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Group Meeting (Focus Group), Questionnaires.
- Who it may be relevant to
- Registry conditions: HIV Infections, Oral Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
People Living With HIV (PLWH), Oral and Oropharyngeal Cancer, and Health Equity: A Qualitative Study
Overview
This is an exploratory qualitative study among People Living With HIV (PLWH) of diverse racial/ethnic and sexual and gender minority (SGM) identities to explore individual, interpersonal, and structural oral health equity factors that serve as barriers or facilitators of accessing oral health care, knowledge and perceptions of human papillomavirus (HPV) vaccination and Oral squamous cell carcinoma (OSCC) /Oropharyngeal squamous cell carcinoma (OPSCC), and to collect recommendations on how to increase access to oral health care and engage PLWH in OSCC/OPSCC prevention.
Detailed description
OBJECTIVES:
1. To identify individual, interpersonal, and structural oral health equity factors (e.g., internalized stigma; enacted stigma; transportation/hours) that serve as barriers or facilitators to accessing regular and appropriate oral health care, among PLWH of intersecting racial/ethnic and SGM groups. 2. To explore knowledge and perceptions about causes, risk factors, prevention, and screening for OSCC/OPSCC and HPV vaccination and if identity group membership influences knowledge and perceptions of these issues. 3. To elicit recommendations for improving access to regular and appropriate oral health care, and suggestions on how to engage PLWH from diverse identity groups in prevention interventions.
OUTLINE:
There will be one screening and enrollment phone call and only one study visit for the Focus Group Discussions (FDGs). A short quantitative survey will be administered.
Interventions
- Other Group Meeting (Focus Group)
Focus Group Discussions (FDGs) will be recorded, transcribed, and coded. - Other Questionnaires
Given electronically or via phone by study team staff
Primary outcome measures
- Identification of potential oral health equity factors [Time frame: Up to 3 days]
Eligibility criteria
Inclusion criteria
- Participants must be 18-years old or older.
- Participants must be individuals living with HIV
- Ability to speak and understand English
- Identify as one or more racial/ethnic minority groups or sexual and gender minority groups
- All genders and members of all races and ethnic groups are eligible for this study.
Exclusion criteria
- Younger than 18-years old.
- Not living with HIV.
- Not able to speak and understand English.
- Not classified as one or more racial/ethnic minority groups or sexual and gender minority groups.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Other
Study locations
United States · 1 center
- University of California, San Francisco — San Francisco
Publications
- Hernandez AL, Lingas EO, Juarez W, Villa A, Palefsky J. Using an anti-racist research framework to design studies of oral human papillomavirus and oropharyngeal cancer in San Francisco: rationale and protocol for the Health Equity and Oral Health in People living with HIV (HEOHP) qualitative study. BMJ Open. 2024 Sep 24;14(9):e091474. doi: 10.1136/bmjopen-2024-091474. PMID 39317508
Identifiers
NCT: NCT06055868 · 23363 · R03DE032972